Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Neil Katz, M.D.

Co-Author

This page shows the publications co-authored by Jeffrey Katz and Daniel Solomon.
Connection Strength

10.670
  1. Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial. Arthritis Rheumatol. 2017 07; 69(7):1374-1380.
    View in: PubMed
    Score: 0.733
  2. Roles of nurse practitioners and physician assistants in rheumatology practices in the US. Arthritis Care Res (Hoboken). 2014 Jul; 66(7):1108-13.
    View in: PubMed
    Score: 0.599
  3. Does motivational interviewing improve medication adherence?-Reply. Arch Intern Med. 2012 Sep 24; 172(17):1351-2.
    View in: PubMed
    Score: 0.530
  4. Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med. 2012 Mar 26; 172(6):477-83.
    View in: PubMed
    Score: 0.509
  5. Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey. Arthritis Care Res (Hoboken). 2012 Feb; 64(2):184-9.
    View in: PubMed
    Score: 0.507
  6. Development of a preliminary index that predicts adverse events after total knee replacement. Arthritis Rheum. 2006 May; 54(5):1536-42.
    View in: PubMed
    Score: 0.340
  7. Which patients with knee problems are likely to benefit from nonarthroplasty surgery? Development of a clinical prediction rule. Arch Intern Med. 2004 Mar 08; 164(5):509-13.
    View in: PubMed
    Score: 0.293
  8. Contribution of hospital characteristics to the volume-outcome relationship: dislocation and infection following total hip replacement surgery. Arthritis Rheum. 2002 Sep; 46(9):2436-44.
    View in: PubMed
    Score: 0.264
  9. Generalist, specialist, or both? J Rheumatol. 2002 Jul; 29(7):1345-7.
    View in: PubMed
    Score: 0.261
  10. Adverse Events and Resource Use Before and After Treat-to-Target in Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2019 09; 71(9):1243-1248.
    View in: PubMed
    Score: 0.212
  11. Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical Trial. Arthritis Care Res (Hoboken). 2018 10; 70(10):1551-1556.
    View in: PubMed
    Score: 0.201
  12. Implementation of Treat-to-Target for Rheumatoid Arthritis in the US: Analysis of Baseline Data From a Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2018 05; 70(5):801-806.
    View in: PubMed
    Score: 0.195
  13. Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: A Cohort Study. Arthritis Rheumatol. 2016 09; 68(9):2106-13.
    View in: PubMed
    Score: 0.174
  14. Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trial. Semin Arthritis Rheum. 2016 08; 46(1):81-7.
    View in: PubMed
    Score: 0.168
  15. Comparison of Care Provided in Practices With Nurse Practitioners and Physician Assistants Versus Subspecialist Physicians Only: A Cohort Study of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2015 Dec; 67(12):1664-70.
    View in: PubMed
    Score: 0.165
  16. Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities. Osteoarthritis Cartilage. 2016 Mar; 24(3):409-18.
    View in: PubMed
    Score: 0.164
  17. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res (Hoboken). 2015 Feb; 67(2):203-15.
    View in: PubMed
    Score: 0.156
  18. Relationships between driving distance, rheumatoid arthritis diagnosis, and disease-modifying antirheumatic drug receipt. Arthritis Care Res (Hoboken). 2014 Nov; 66(11):1634-43.
    View in: PubMed
    Score: 0.153
  19. Predictors of stopping and starting disease-modifying antirheumatic drugs for rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014 Aug; 66(8):1152-8.
    View in: PubMed
    Score: 0.151
  20. Sociodemographic, disease, health system, and contextual factors affecting the initiation of biologic agents in rheumatoid arthritis: a longitudinal study. Arthritis Care Res (Hoboken). 2014 Jul; 66(7):980-9.
    View in: PubMed
    Score: 0.150
  21. Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis? Arthritis Rheumatol. 2014 Apr; 66(4):775-82.
    View in: PubMed
    Score: 0.147
  22. Comparative risk of fracture in men and women with HIV. J Clin Endocrinol Metab. 2014 Feb; 99(2):486-90.
    View in: PubMed
    Score: 0.144
  23. Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res (Hoboken). 2013 May; 65(5):703-11.
    View in: PubMed
    Score: 0.138
  24. Surgery versus physical therapy for a meniscal tear and osteoarthritis. N Engl J Med. 2013 May 02; 368(18):1675-84.
    View in: PubMed
    Score: 0.137
  25. Treatment of rheumatoid arthritis in the Medicare Current Beneficiary Survey. Arthritis Res Ther. 2013 Mar 18; 15(2):R43.
    View in: PubMed
    Score: 0.137
  26. Adipokine hormones and hand osteoarthritis: radiographic severity and pain. PLoS One. 2012; 7(10):e47860.
    View in: PubMed
    Score: 0.133
  27. The MeTeOR trial (Meniscal Tear in Osteoarthritis Research): rationale and design features. Contemp Clin Trials. 2012 Nov; 33(6):1189-96.
    View in: PubMed
    Score: 0.132
  28. The relationship between hand osteoarthritis and serum leptin concentration in participants of the Third National Health and Nutrition Examination Survey. Arthritis Res Ther. 2012 May 31; 14(3):R132.
    View in: PubMed
    Score: 0.130
  29. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J Bone Miner Res. 2011 May; 26(5):993-1001.
    View in: PubMed
    Score: 0.120
  30. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther. 2011 Feb 23; 13(1):R32.
    View in: PubMed
    Score: 0.119
  31. Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med. 2011 Feb 15; 154(4):217-26.
    View in: PubMed
    Score: 0.119
  32. Development and preliminary validation of a meniscal symptom index. Arthritis Care Res (Hoboken). 2011 Feb; 63(2):208-15.
    View in: PubMed
    Score: 0.118
  33. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J Bone Miner Res. 2010 Nov 18.
    View in: PubMed
    Score: 0.117
  34. Decreasing medical complications for total knee arthroplasty: effect of critical pathways on outcomes. BMC Musculoskelet Disord. 2010 Jul 14; 11:160.
    View in: PubMed
    Score: 0.114
  35. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med. 2009 Jun 22; 169(12):1113-21; discussion 1121-2.
    View in: PubMed
    Score: 0.106
  36. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study. Arthritis Res Ther. 2008; 10(4):R95.
    View in: PubMed
    Score: 0.100
  37. Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis. Am Heart J. 2008 Aug; 156(2):336-41.
    View in: PubMed
    Score: 0.099
  38. Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med. 2008 May 06; 148(9):637-46.
    View in: PubMed
    Score: 0.098
  39. High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in Pennsylvania. Int Q Community Health Educ. 2008-2009; 29(3):223-40.
    View in: PubMed
    Score: 0.095
  40. Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol. 2008 Feb; 35(2):319-26.
    View in: PubMed
    Score: 0.095
  41. Percutaneous vertebroplasty among low income Medicare beneficiaries. Spine (Phila Pa 1976). 2007 Dec 01; 32(25):2910-4.
    View in: PubMed
    Score: 0.095
  42. Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res. 2007 Nov; 22(11):1808-15.
    View in: PubMed
    Score: 0.094
  43. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum. 2007 Aug 15; 57(6):928-34.
    View in: PubMed
    Score: 0.093
  44. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007 Jun; 56(6):1754-64.
    View in: PubMed
    Score: 0.092
  45. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement. Arthritis Rheum. 2006 Dec 15; 55(6):873-7.
    View in: PubMed
    Score: 0.089
  46. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum. 2006 Dec; 54(12):3790-8.
    View in: PubMed
    Score: 0.089
  47. The patient's perspective on the recall of Vioxx. J Rheumatol. 2006 Jun; 33(6):1082-8.
    View in: PubMed
    Score: 0.086
  48. The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28. Arthritis Res Ther. 2006; 8(3):R57.
    View in: PubMed
    Score: 0.084
  49. Educational outreach (academic detailing) regarding osteoporosis in primary care. Pharmacoepidemiol Drug Saf. 2005 Dec; 14(12):843-50.
    View in: PubMed
    Score: 0.083
  50. Compliance with osteoporosis medications. Arch Intern Med. 2005 Nov 14; 165(20):2414-9.
    View in: PubMed
    Score: 0.082
  51. Performance of a rheumatoid arthritis records-based index of severity. J Rheumatol. 2005 Sep; 32(9):1679-87.
    View in: PubMed
    Score: 0.081
  52. Does practice make perfect? Arthritis Rheum. 2005 Jun; 52(6):1628-31.
    View in: PubMed
    Score: 0.080
  53. Older adults' knowledge and beliefs about osteoporosis: results of semistructured interviews used for the development of educational materials. J Rheumatol. 2005 Apr; 32(4):673-7.
    View in: PubMed
    Score: 0.079
  54. Development and assessment of indicators of rheumatoid arthritis severity: results of a Delphi panel. Arthritis Rheum. 2005 Feb 15; 53(1):61-6.
    View in: PubMed
    Score: 0.078
  55. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005 Feb; 80(2):194-202.
    View in: PubMed
    Score: 0.078
  56. Osteoporosis action: design of the healthy bones project trial. Contemp Clin Trials. 2005 Feb; 26(1):78-94.
    View in: PubMed
    Score: 0.078
  57. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004 Jul; 19(7):783-90.
    View in: PubMed
    Score: 0.075
  58. Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis Rheum. 2004 Jun 15; 51(3):383-7.
    View in: PubMed
    Score: 0.075
  59. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003 Oct 01; 115(5):398-400.
    View in: PubMed
    Score: 0.071
  60. Trends in knee magnetic resonance imaging. Med Care. 2003 May; 41(5):687-92.
    View in: PubMed
    Score: 0.069
  61. Effectiveness of clinical pathways for total knee and total hip arthroplasty: literature review. J Arthroplasty. 2003 Jan; 18(1):69-74.
    View in: PubMed
    Score: 0.067
  62. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum. 2002 Dec; 46(12):3136-42.
    View in: PubMed
    Score: 0.067
  63. Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee Replacement. Arthritis Care Res (Hoboken). 2021 Jan 15.
    View in: PubMed
    Score: 0.059
  64. Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee Replacement. JAMA Netw Open. 2019 07 03; 2(7):e198061.
    View in: PubMed
    Score: 0.053
  65. Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees. Osteoarthritis Cartilage. 2019 10; 27(10):1445-1453.
    View in: PubMed
    Score: 0.053
  66. Association of Geography and Access to Health Care Providers With Long-Term Prescription Opioid Use in Medicare Patients With Severe Osteoarthritis: A Cohort Study. Arthritis Rheumatol. 2019 05; 71(5):712-721.
    View in: PubMed
    Score: 0.052
  67. Cost-Effectiveness of Tramadol and Oxycodone in the Treatment of Knee Osteoarthritis. Arthritis Care Res (Hoboken). 2017 Feb; 69(2):234-242.
    View in: PubMed
    Score: 0.045
  68. Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity. Arthritis Care Res (Hoboken). 2016 12; 68(12):1743-1750.
    View in: PubMed
    Score: 0.044
  69. Trends in prescription of opioids from 2003-2009 in persons with knee osteoarthritis. Arthritis Care Res (Hoboken). 2014 Oct; 66(10):1489-95.
    View in: PubMed
    Score: 0.038
  70. Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer. Pharmacoepidemiol Drug Saf. 2013 Nov; 22(11):1239-44.
    View in: PubMed
    Score: 0.035
  71. Placing a price on medical device innovation: the example of total knee arthroplasty. PLoS One. 2013; 8(5):e62709.
    View in: PubMed
    Score: 0.035
  72. Medical device innovation--is "better" good enough? N Engl J Med. 2011 Oct 20; 365(16):1464-6.
    View in: PubMed
    Score: 0.031
  73. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors. Osteoporos Int. 2011 Mar; 22(3):943-54.
    View in: PubMed
    Score: 0.028
  74. Confounder summary scores when comparing the effects of multiple drug exposures. Pharmacoepidemiol Drug Saf. 2010 Jan; 19(1):2-9.
    View in: PubMed
    Score: 0.027
  75. Ambulatory visit utilization in a national, population-based sample of adults with osteoarthritis. Arthritis Rheum. 2009 Dec 15; 61(12):1694-703.
    View in: PubMed
    Score: 0.027
  76. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum. 2006 Sep; 54(9):2757-64.
    View in: PubMed
    Score: 0.022
  77. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy? Arch Intern Med. 2002 Jul 08; 162(13):1509-14.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.